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Abstract  
Since the discovery of ‘protein kinase activity’ in 1954, close to 600 kinases have been 
discovered that play a critical role in cell physiology. In several pathological conditions, 
aberrant protein kinase activity leads to abnormal cell and tissue physiology. Therefore, 
protein kinase inhibitors are investigated as potential treatments for several diseases, 
including dementia, diabetes, cancer, autoimmune and cardiovascular disease. Modern 
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semiconductor technology has recently been applied to accelerate the discovery of novel 
protein kinase inhibitors that may become the standard of care drugs of tomorrow. Here 
we describe current techniques and novel applications of semiconductor technologies in 
protein kinase inhibitor drug discovery. 
 
Teaser 
Semiconductor technology opens new frontiers in the detection of biochemical reactions 
in vitro. Here, we describe its application to the field of protein phosphorylation reserch 
and kinase inhibitor drug discovery. 
 
Introduction 
The therapeutic need for novel and efficacious treatments remains unmet for several 
human diseases. In addition, even when effective treatments are available, the onset of 
drug resistance or the occurrence of side effects associated with prolonged drug use 
requires the discovery of novel drugs [1]. The acceleration of the drug discovery cycle 
remains a priority in several biomedical fields and will depend on the availability of 
new tools for drug screening in academia and industry. Protein kinase inhibitors are one 
of the most important target groups for drug development [2]. Nonetheless, only a small 
portion of human protein kinases can be effectively modulated using specific inhibitors 
[3]. To date, more than 400 diseases are reported to be caused either directly or 
indirectly by deregulation or mutation of protein kinases [4], and over 200 protein 
kinase genes map to disease loci or cancer amplicons [5]. The drug development 
opportunities are enormous, but the rate of discovery and approval of new protein 
kinase-targeting drugs remains low [6, 7]. Part of the problem resides in the in vitro 
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assays used for the primary screening of compounds that inhibit or modulate protein 
kinase activity.  
The most common techniques used to investigate protein kinase activity are kinase 
assay sthat use 32-phosphorus (32P) labelling of peptides designed to mimic the kinases 
target sequences [8] or phosphor-specific immunodetection assays (e.g. ELISA, 
immunoblots or flow cytometry), which rely on antibodies selectively recognising their 
targets when phosphorylated [9], or spectroscopic techniques with nanoparticles acting 
as markers for phosphorylation [10]. Mass spectrometry-based detection of protein 
phosphorylation or phosphoproteomics has also become a very important technique in 
protein kinase investigations [11]. Despite recent developments facilitating their use for 
basic research and target identification (e.g. [12]), none of the above techniques has the 
high throughput necessary for primary drug screening. For drug discovery purposes, 
binding assays are utilised to test the ability of putative compounds to inhibit the 
interaction of protein kinases with their protein substrates [13] or their binding of ATP 
[14]. Fluorescence-based assays have also become widely used for the screening of 
large libraries of compounds and development of new drugs [15]. Fluorescent 
biosensors for protein kinase studies entail a biochemical moiety that recognizes the 
target kinase in its active state (e.g. a substrate or binding domain), which is coupled to 
a fluorescent probe and therefore transduces kinase activation into a measurable signal. 
Both traditional binding or fluorescence biosensor-based assays have an important 
limitation: they identify molecules targeting the specific molecular event that they 
measure (i.e. binding to specific ligand or binding of ATP). This leads to the loss as 
false negatives of compounds targeting other aspects of the enzymatic reaction, which is 
responsible for a weak correlation between binding/fluorescence-based screenings and 
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kinase activity assay results [16]. Screening results based on binding assays can 
therefore be misinterpreted and promising protein kinase inhibitors can be missed. 
Similarly, drug screenings based on the detection of endpoint functional responses (e.g. 
cell apoptosis, proliferation or metabolic throughput), have the important limitation of 
identifying compounds affecting the event providing the readout signal, rather than 
directly binding and modulating protein kinases.  
We have recently described a novel method based on the use of an 
electrolyte-insulator-semiconductor (EIS) for the detection of the protein 
phosphorylation reaction [17-19]. This methods has several advantages over existing 
methods, including: 1) identification of compounds interfering with different aspects of 
the catalytic mechanism of protein kinases (rather than just interfering with ATP- or 
substrate-binding); 2) detection of phosphorylation in real time and monitoring the rate 
of phosphorylation reactions, therefore allowing kinetics studies (rather than relying on 
the end-point detection of reaction products – i.e. phosphorylated substrates by 32-P 
incorporation and phospho-dependent immunodetection); 3) high throughput and 
potential for upscaling; 4) low cost.  
 
Semiconductor technology applied to biology and drug discovery  
Recent developments in the semiconductor technology may open a new era for drug 
discovery research, characterised by assays capable of screening thousands of inhibitors 
of kinases in a single run. The most cost-effective way to apply semiconductor 
technology to the realm of chemical or biological sensing is by using field effect 
devices (FEDs) such as ion-sensitive field effect transistor (ISFETs) and EIS.  
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ISFETs measure the changes of potential on the interface between a dielectric material 
and an electrolyte, typically as a result of the adsorption of ions on the surface of the 
material. Several dielectric materials used in the semiconductor industry – such as, for 
example, silicon nitride and aluminium oxide – are pH sensitive (i.e. adsorb H+ ions).  
A large number of intra/inter cellular reactions involve charge transfer or release of 
protons. Upon surface immobilization of substrates or enzymes, the release of protons 
or the minute changes in electrical charge associated with chemical reactions can 
therefore be measured. A commonly used pH sensitive material is silicon nitride, which 
in our recent studies has been employed to measure the release of protons associated 
with protein phosphorylation [17-19]. The surface charge of the silicon nitride can be 
measured by integrating it with a semiconductor in form of an ISFET or EIS sensor.  
The detection mechanism of EIS is similar to the operation of ISFETs. The difference 
lies in the fact that the EIS is a two-terminal capacitor structure, while the ISFET has 
extra contacts on doped regions of the semiconductor to operate as a three-terminal 
transistor. The adsorption of ions on the surface of the dielectric material creates an 
electric field across the dielectric material, inducing changes in the underlying 
semiconductor. The mechanism can be explained by site binding theory, which relates 
the solid-liquid interface potential to local pH changes in the solution [20]. In the case 
of silicon nitride, at the dielectric material/solution interface, Si3N4 presents active sites 
in the form of neutral surface hydroxyl (SiOH) groups, which capture H+ ions released 
by chemical reactions until thermodynamic equilibrium is established, as described by 
the following reaction: 
SiOHଶା ↔ SiOH ൅ Hା	 
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After the hydrogen ion is captured by the silicon nitride, the surface potential of the 
structure changes. If this structure acts as the gate of the transistor, gate to source 
voltage of the transistor would also change. Equation 1.1 below shows the dependence 
of the semiconductor surface potential (߶௦) on the hydrogen ion concentration:  
߶௦ ൌ 	െ ܥଵܥ௛ ሺܧଵ݀ଶ ൅ ܧଶ݀ଶሻ ൅ ߶ௗ ൅
ݍ ௦ܰ௜௟
ܥ௛ ቊ
ሾܪ௦ାሿଶ െ ܭାܭି
ሾܪ௦ାሿଶ ൅ ܭାሾܪ௦ାሿ ൅ ܭାܭିቋ
൅ ݍ ௦ܰ௜௟ܥ௛ ቊ
ሾܪ௦ାሿଶ െ ܭାܭି
ሾܪ௦ାሿ ൅ ܭேା ቋ					ሺ1.1ሻ 
where C1 is the accumulation capacitance due to the two dielectric layers, namely Si3N4 
and SiO2 in the structure that has been used. ܧଵ,ଶ and ݀ଵ,ଶ denote the electric field and 
thickness of each dielectric layer. ܥ௛ is the Helmholtz layer capacitance per unit area, 
௦ܰ௜௟ is the number of silanol sites per unit area and K+/- is the dissociation constant for 
the chemical reaction at the insulator. It is apparent from Equation 1.1 that a highly 
sensitive pH sensor would require a relatively large value of Nsil. The presence of two 
dielectric layers increases the pH sensitivity of the surface. With two dielectric layers, 
as compared with a single insulator structure with the same concentration of H+ ions on 
the surface, higher surface potential is achieved. This increase in surface potential 
decreases the threshold seen by the channel at the transistor gate. As a result, at a given 
voltage, the depletion charge increases at higher concentration of H+ ions. 
The surface potential (ϕ_s) on the insulator of EIS structure is measured by capacitance 
voltage characterisation. In this technique, a dc voltage superimposed with a small ac 
signal is applied across the EIS structure and the capacitance of the structure is 
measured. There are three distinct regions of the curve: 1) inversion 2) depletion and 3) 
accumulation. The inversion region is formed with minority charge carriers and the 
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accummulation region is formed by the majority carriers in the bulk substrate. When a 
low frequency ac signal (less than 100 Hz) is applied, the saturation values of inversion 
and accumulation coincide with each other. On increasing the frequency, the inversion 
capacitance decreases because at high frequencies (greater than 1 kHz) the generation 
rate is not fast enough to allow the formation of minority carriers at the 
insulator-semiconductor interface. However, the accumulation and depletion 
capacitances do not vary with the change in the frequency. The accumulation 
capacitance is the intrinsic capacitance of the structure (due to the thickness and 
dielectric constant of the insulator), which is independent on any charges on the surface. 
Any charges on the surface, for instance protein charge or a pH change on the surface, 
are reflected on the voltage required to induce depletion (the threshold voltage).  
ISFETS have been used extensively for decades for pH sensing applications (with 
variable degrees of commercial success). However, despite their amenability for 
biochemical sensing the only ISFET based high-throughput technology commercially 
released so far is Ion Torrent whole genome sequencing system.. Currently, this 
technology appears to be the cheapest and most time effective solution for 
whole-genome sequencing. FEDs can function as micro-pH sensors and measure the 
release of protons associated with chemical reactions. There is a large number of 
chemical reactions in the human body that involve release of protons that could be 
readily detected by both ISFETs and EISs, including protein phosphorylation.  
The major advantage of using FED-based devices is their high throughput capabilities. 
The potential of very large scale integration technology (VLSI) to form an array of 
FEDs to monitor biocatalytic transformation has been exploited by Ion Torrent on their 
DNA sequencing chip [20]. This technology allows whole genome sequencing on a chip 
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by detection of protons released by the elongation of DNA primer molecules during a 
polymerase chain reaction (PCR). The release of protons is measured by an array of 
ISFETs. Similarly, the release of proton associated with phosphorylation of proteins or 
other biochemical reactions can be easily measured by FEDs. Such a system would 
enable the analysis of different biochemical reactions and the screening of various 
inhibitors (drugs) in an effective and convenient manner [22]. Therefore, its application 
in the development of miniaturised drug discovery platforms is promising and deserves 
attention. 
Protein phosphorylation on EIS Sensors 
EIS sensors have become established in the biosensing community as powerful tools to 
detect pH changes in highly resolved temporal and spatial patterns [23, 24]. In the 
context of protein phosphorylation, there have been previous studies focusing on the 
detection of the change in substrate protein electrical charge rather than on the release of 
protons in the protein kinase reaction. Freeman et al. were the first to study the degree 
of gate surface charging detectors due to kinase activity [25]. They used an aluminium 
oxide gated ISFET to follow the phosphorylation of proteins. This system allowed 
monitoring of both phosphorylation and dephosphorylation in real-time, leading to the 
estimation of phosphorylation reaction kinetics. Electrochemical detection of protein 
kinase activity using FEDs has been demonstrated in several relevant studies using 
different semiconductive materials, such as silicon [26], indium tin oxide (ITO) [27] 
and boron-doped diamond [28]. In other studies, different reagents were utilised to 
enhance the detection of the protein kinase reaction, including TiO2/silver nanoparticles 
[29] and Carbon nanotubes (CNTs) [30]. The same authors also demonstrated the use of 
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gold nanoparticles combined with semiconductor technology to obtain the 
electrochemical detection of the enzymatic reaction catalysed by tyrosine protein 
kinases [31]. 
In our recent work, we demonstrated that a semiconductor-based EIS can be applied to 
dual detection of proton release and surface charge change associated with the 
phosphorylation of surface-absorbed proteins [17-19]. Figure 1 shows a detection 
scheme for dual mode biosensing employed by Bhalla et al. [17]. In this work the 
authors used Si3N4-based EIS structures as well as gold–insulator–semiconductor 
capacitor structures for the detection of pH and electrical charge changes associated 
with phosphorylation of proteins, respectively. In both methods, a conventional 
three-electrode electrochemical setup was employed with an Ag/AgCl reference 
electrode immersed in the electrolyte via a salt bridge, used to apply the gate voltage, 
and a platinum (Pt) counter electrode. The Capacitance-Voltage (CV) charactertsics of 
the sensor were monitored to detect the kinase activity. 
Upon kinase-mediated protein phosphorylation, each amino acid undergoing 
phosphorylation releases a proton that is adsorbed onto the Si3N4 surface. As a result, 
the threshold potential of the structure decreases and a change in potential is observed. 
The longer the reaction with kinase/ATP is left to progress, the higher the Vg changes 
that are achieved. Our studies demonstrated the use of EIS to study phosphorylation of 
myelin basic protein (MBP) by PKC- in the presence of a phosphate source (ATP 
/ATP-S) [17-19]. The phosphorylation reaction and its inhibition could be detected, as 
the phosphorylation reaction was associated with significantly higher signal (37 mV) 
compared to the inhibited reaction (5 mV).  
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Similar results were obtained when reaction was performed using ATP-S instead of 
ATP. The use of ATP-S for phosphorylation adds a thiol group to the protein upon 
phosphorylation. The thiophosphorylation of proteins allowed the use of AuNPs (16 nm 
mean size), wherein the affinity between the thiol groups and Au resulted in the binding 
of AuNPs. As a consequence, the phosphorylated protein was labelled with AuNPs 
which enabled its detection by localised surface plasmon resonance (LSPR), alongside 
pH changes on the EIS substrate. Upon thiophosphorylation, a red-shift of 31 nm in the 
absorption spectrum of silicon nitride was observed. The reaction performed in the 
presence of kinase inhibitor revealed less than 10 nm of shift, confirming that the large 
redshift in the wavelength of thiophosphorylated sample was due to the covalent 
attachment of AuNPs to the sulphide group present on the γ-phosphate group transferred 
from ATP-S to the MBP (Figure 2).  
The findings of Bhalla et al. [17] strongly argue for the use of electrical and optical 
detection as orthogonal tool to detect kinase activity in a single experiment. 
Complementary characterisation techniques are often required to characterize and 
validate biomolecular interactions. The authors work shows two orthogonal techniques 
being used on a single platform for fast and miniaturised biosensing. Each technique 
provides different information, which can then be correlated to standard curves of 
analyte concentration. In the case of the presented dual LSPR and EIS semiconductor 
system, EIS provides real time information on phosphorylation kinetics, while LSPR 
confirms the reaction completion.  In addition, because LSPR readouts inherently 
change upon nanoparticle binding to the substrate, in cases of lower phosphorylation 
activity, where it would be difficult to detect the phosphorylation reaction using only an 
EIS system, LSPR facilitates the detection of the reaction and its completion. 
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Conclusions and Outlook 
Semiconductor EIS devices display remarkable performances in the detection of protien 
phosphorylation. Development of arrays of such structures with microfluidics can be 
utilised for the development of an automated device that can be used to screen novel 
inhibitors of kinases. Using complementary metal oxide semiconductor (CMOS) and 
VLSI technology, it could be possible to design a high throughput platform for 
screening inhibitors of protein kinases.  
This technique has so far been tested using recombinantly expressed active protein 
kinases and their peptide substrates. Although the generation of substrates by 
customised peptide synthesis is easily achievable and inexpensive, the availability of 
catalytically active protein kinases may represent a bottle neck for the implementation 
of this approach. On this respect, it must be noted that an increasing number of protein 
kinases are commercially available as catalytically active enzymes through a number of 
specialised manufacturers and suppliers. Where the desired protein kinases is not readily 
available, modern molecular biology and expression systems in eukaryotic cells are 
readily available for cloning and expression of protein kinases as catalytically active 
enzymes [32, 33]. In addition, although this option has not been experimentally tested, 
further development may enable the use of cell lysates or tissue extracts as sources of 
active kinases. This approach would simplify the technique, reduce the costs and allow 
the investigation of disease states for which the responsible kinase is yet unknown.  
A final advantage of the use of semiconductors for drug discovery in particular and 
biosensing in general is their amenability to technology multiplexing. By combining 
several orthogonal detection technologies on a single platform, a robust system for 
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compound screening could be designed. The integration of multiple technologies on a 
single biosensor is theoretically possible and could allow the parallel study of more than 
one biochemical parameter at once, such as association/dissociation constant, real-time 
kinetics, rate of product formation, etc. This can provide important information about 
the characteristics of drugs under development in a convenient manner.   
 
Figure legends 
Figure 1 (A) Immobilised protein on silicon nitride surface. (B) Upon 
thiophosphorylation there is a release of proton (which allows EIS-dependent 
monitoring of the reaction) and transfer of γ phosphate from ATP-S. (C) Covalent 
attachment of AuNPs to the sulphide group on thiophosphorylated protein. (D) LSPR 
detection mechanism 
Figure 2: (a) LSPR spectra in the absorption mode for samples thiophosporylated and 
controls (without kinase activator, ATP phosphorylation, and in the presence of an 
inhibitor), as well as for the Si3N4 background. (b) Kinase activity detected by 
measuring the release of proton associated with protein phosphorylation for the same 
samples shown in 2a. 
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AB
Research Highlights: 
 We developed a new dual detection technology for protein phosphorylation 
 It combines electrolyte-insulator-semiconductor and localised surface plasmon 
resonance  
 It does not require radioactive labelling or phospho-specific antibodies 
 It offers the possibility to follow the phosphorylation reaction in real time 
 It is a formidable tool for kinase inhibitor drug discovery  
 
